Search

everythinglearnresearchcommunity

for

Search:↓

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

Platelet-rich plasma (PRP) can help restore hair, but the best method for preparing and using it is still unclear.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Bioprinting could greatly improve health outcomes but faces challenges like material choice and ensuring long-term survival of printed tissues.

Early treatment of COVID-19-related hair loss is crucial for better outcomes.

The document concludes that freeze-dried platelet-rich plasma shows promise for medical use but requires standardization and further research.

Mesotherapy is a promising alternative to minoxidil for hair loss with mild side effects.

People undergoing chemotherapy need better support and information to cope with hair loss.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Platelet-rich plasma may improve hair density and count in male pattern hair loss, but more high-quality research is needed.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

PRP shows promise but lacks consistent evidence and regulation.

Fat-derived stem cells, platelet-rich plasma, and biomaterials show promise for healing chronic skin wounds and improving soft tissue with few side effects.

PRP is an effective and safe treatment for hair loss.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

People with non-scarring hair loss often have lower vitamin D levels than those without hair loss.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

Spironolactone can effectively treat hair loss with manageable side effects.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.